Sirshendu Chaudhuri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sirshendu Chaudhuri has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- A. Y. Nirupama
Indian Institute of Public Health, Hyderabad, India
1 shared publication - Gudlavalleti Venkata S Murthy
Pragyaan Sustainable Health Outcomes (PRASHO) Foundation, 2nd Floor World Trade Center, Nanakramguda, Hyderabad, 500032, India
1 shared publication Gvs Murthy
Indian Institute of Public Health, Hyderabad, Telangana, India
1 shared publicationHemanth Kumar
Indian Institute of Public Health, Hyderabad, Telangana, India
1 shared publicationHira Pant
Indian Institute of Public Health, Hyderabad, Telangana, India
1 shared publicationPraveen Vashist
Community Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
1 shared publication
Latest Publications
- Open Access
- 8 March 2024
- Published by Wolters Kluwer Health in Indian Journal Of Ophthalmology
- Vol. 72 (7) , 994-1000
Prevalence of blindness and visual impairment in a coastal region of Southern India: A cross-sectional survey in Prakasam district, Andhra Pradesh
Purpose: To estimate the magnitude, determinants, and causes of visual impairment (VI) and blindness among people >40 years. Methods: In this cross-sectional survey, 2,968 people >40 years from 34 clusters were examined. A cluster random sampling method with a compact segment sampling technique was used to select the study participants. Prevalence of any VI (presenting visual acuity (PVA) P value of less than 0.05 was considered statistically significant. Results: The mean age of the participants was 54.6 years (Standard deviation ± 11.2 years). The prevalence of mild, moderate, and severe visual impairment was 14.2% (12.95–15.49), 13.7% (12.46–14.97), and 0.7% (0.47–1.12), respectively. The prevalence of blindness was 1.3% (0.94–1.79, n = 39). The overall prevalence of VI (presenting Visual Acuity 70 years, and OR 7.6 (95% CI: 2.2–26.5) for people aged between 60 and 69 years compared to those aged 41–50 years and people living near coastal regions (Within 50 km of coast) (OR: 3.9, 95% CI: 1.6–7.3). Conclusion: Blindness and vision impairment are of public health concern in this geographic region. Eye care services need to be augmented to address this challenge.
- 8 March 2024
- Published by Wolters Kluwer Health in Indian Journal Of Ophthalmology
- Vol. 72 (7) , 994-1000
Open AccessPrevalence of blindness and visual impairment in a coastal region of Southern India: A cross-sectional survey in Prakasam district, Andhra Pradesh
Purpose: To estimate the magnitude, determinants, and causes of visual impairment (VI) and blindness among people >40 years. Methods: In this cross-sectional survey, 2,968 people >40 years from 34 clusters were examined. A cluster random sampling method with a compact segment sampling technique was used to select the study participants. Prevalence of any VI (presenting visual acuity (PVA) P value of less than 0.05 was considered statistically significant. Results: The mean age of the participants was 54.6 years (Standard deviation ± 11.2 years). The prevalence of mild, moderate, and severe visual impairment was 14.2% (12.95–15.49), 13.7% (12.46–14.97), and 0.7% (0.47–1.12), respectively. The prevalence of blindness was 1.3% (0.94–1.79, n = 39). The overall prevalence of VI (presenting Visual Acuity 70 years, and OR 7.6 (95% CI: 2.2–26.5) for people aged between 60 and 69 years compared to those aged 41–50 years and people living near coastal regions (Within 50 km of coast) (OR: 3.9, 95% CI: 1.6–7.3). Conclusion: Blindness and vision impairment are of public health concern in this geographic region. Eye care services need to be augmented to address this challenge.
- 6 March 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (2) , 1-7
Therapeutic HPV Vaccination: A Strategy for Cervical Cancer Elimination in India
- 6 March 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (2) , 1-7
Therapeutic HPV Vaccination: A Strategy for Cervical Cancer Elimination in India